Nisa Investment Advisors LLC Grows Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Nisa Investment Advisors LLC boosted its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 12.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 136,889 shares of the real estate investment trust's stock after buying an additional 15,416 shares during the period. Nisa Investment Advisors LLC owned 0.05% of Omega Healthcare Investors worth $5,571,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in OHI. Daiwa Securities Group Inc. lifted its position in Omega Healthcare Investors by 1,030.8% during the second quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust's stock valued at $32,384,000 after acquiring an additional 861,907 shares during the last quarter. Marshall Wace LLP acquired a new stake in shares of Omega Healthcare Investors in the 2nd quarter worth $20,962,000. BROOKFIELD Corp ON purchased a new position in Omega Healthcare Investors during the 1st quarter worth $16,446,000. Dimensional Fund Advisors LP raised its stake in Omega Healthcare Investors by 7.9% in the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust's stock valued at $127,831,000 after buying an additional 272,299 shares during the last quarter. Finally, Sei Investments Co. grew its stake in shares of Omega Healthcare Investors by 150.8% during the second quarter. Sei Investments Co. now owns 298,761 shares of the real estate investment trust's stock worth $10,233,000 after acquiring an additional 179,623 shares during the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock traded down $1.29 during mid-day trading on Friday, hitting $41.18. The company had a trading volume of 1,900,902 shares, compared to its average volume of 1,648,304. The company has a market capitalization of $10.62 billion, a price-to-earnings ratio of 31.20, a P/E/G ratio of 1.37 and a beta of 1.00. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $44.42. The company's fifty day moving average is $40.42 and its 200-day moving average is $35.89. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 9.19% and a net margin of 34.41%. The firm had revenue of $252.70 million for the quarter, compared to analysts' expectations of $205.92 million. During the same period last year, the company posted $0.74 earnings per share. The business's quarterly revenue was up 17.5% on a year-over-year basis. Equities research analysts predict that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.51%. The ex-dividend date of this dividend is Monday, November 4th. Omega Healthcare Investors's dividend payout ratio (DPR) is presently 197.06%.

Analyst Ratings Changes

A number of analysts recently commented on the stock. BNP Paribas upgraded shares of Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 target price for the company in a research note on Thursday. Truist Financial boosted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a report on Wednesday, September 4th. Wells Fargo & Company restated an "overweight" rating and issued a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. BMO Capital Markets lifted their price target on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a "market perform" rating in a research report on Monday, October 7th. Finally, Berenberg Bank assumed coverage on Omega Healthcare Investors in a report on Friday, October 18th. They issued a "buy" rating and a $45.00 price objective on the stock. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Omega Healthcare Investors has an average rating of "Hold" and a consensus target price of $39.70.

Insider Activity at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of the company's stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now directly owns 183,076 shares of the company's stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Daniel J. Booth sold 56,725 shares of the business's stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares of the company's stock, valued at $4,025,000. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.